Status:
ACTIVE_NOT_RECRUITING
Mindfulness-Associated Brain Changes in Adults With Autism
Lead Sponsor:
Arizona State University
Collaborating Sponsors:
Southwest Autism Research and Resource Center (SARRC)
Banner Alzheimer's Institute
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study to measure brain functioning before and after stress-reduction classes to better understand how symptom improvements relate to brain functioning in adults with ASD (Autism Sp...
Eligibility Criteria
Inclusion
- Age 18 to 89 years old, with a special focus on adults with ASD who are going to college given the additional stress of this phase in life. We are recruiting participants across a broad age range in order to maximize our ability to inform interventions for adults with ASD. The upper age limit of 89 years was selected so a de-identified dataset can be created with all participant ages included.
- ASD diagnosis via gold-standard diagnostic assessments (Autism Diagnostic Observation Schedule-2).
- Must be able to attend at least 7 of the 8 weekly intervention classes.
- English speaking: Participants must be English-speaking because the screening and behavioral measures are in English (including the intelligence estimate).
Exclusion
- Participants with Intelligence Quotient (IQ) scores \<70 will be excluded to minimize variability due to general cognitive functioning.
- Report of any major medical illnesses, histories of seizures, or head trauma with loss of consciousness. These health factors can cause brain changes that would confound findings.
- Concerns that the participant may not be able to complete the MRI neuroimaging requirements for the study, including claustrophobia or metal objects within the participant's body or eyes. Implanted metal objects may create a safety hazard in the powerful magnetic field during MRI imaging.
- Pregnant women. MRI has no known effects on pregnancy or fertility. However, since we are not 100% certain MRI has no effects on a developing fetus, women who are pregnant may not participate in this study.
Key Trial Info
Start Date :
May 6 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04017793
Start Date
May 6 2019
End Date
December 31 2024
Last Update
January 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arizona State University
Tempe, Arizona, United States, 85281